Neuberger Berman Group
MDGL icon

Neuberger Berman Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Neuberger Berman Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.73M Sell
12,849
-5,811
-31% -$2.78M 0.01% 922
2025
Q4 		$10.9M Buy
18,660
+129
+0.7% +$65.9K 0.01% 787
2025
Q3 		$8.5M Buy
+18,531
New +$6.91M 0.01% 840
2025
Q2 		– Sell
-692
Closed -$229K – 2099
2025
Q1 		$229K Sell
692
-21,436
-97% -$7.04M ﹤0.01% 1785
2024
Q4 		$6.83M Buy
+22,128
New +$6.22M 0.01% 885
2023
Q4 		– Sell
-6,817
Closed -$996K – 1898
2023
Q3 		$996K Buy
+6,817
New +$1.28M ﹤0.01% 1257
2013
Q4 		– Sell
-1,126
Closed -$249K – 1642
2013
Q3 		$249K Sell
1,126
-43
-4% -$9.15K ﹤0.01% 1458
2013
Q2 		$204K Buy
+1,169
New +$305K ﹤0.01% 1491

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return